Company: RGNT
Filing Date: 2025-05-05
Form Type: F-1/A
Source: 0001213900-25-039589
Chunk: 48

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-05-05
Form: F-1/A
Chunk 48
---
 involving patents or other intellectual property, including interference proceedings,
post grant review and inter partesreview before the USPTO or the equivalent foreign patent authority, the possibility exists that
we may be in the future. A legal proceeding, regardless of the outcome, could drain our financial resources and divert the time and effort
of our management. Protracted litigation to defend or prosecute our intellectual property rights could result in our customers or potential
customers deferring or limiting their purchase or use of the affected products until resolution of the litigation.

<div align='center'>30</div>

If we are found to infringe
a third party’s intellectual property rights, we could be required to obtain a license from such third party to continue selling,
developing and marketing our products and techniques. However, we may not be able to obtain any required license on commercially reasonable
terms or at all. Even if we were able to obtain a license, it could be non-exclusive, thereby giving our competitors access to the same
technologies licensed to us. We could be forced, including by court order, to cease commercializing the infringing technology or product.
In addition, we could be found liable for monetary damages, including treble damages and attorneys’ fees if we are found to have
willfully infringed a patent. A finding of infringement could force us to cease some of our business operations, which could materially
harm our business. Claims that we have misappropriated the confidential information or trade secrets of third parties could have a similar
negative impact on our business. Intellectual property litigation may lead to unfavorable publicity that harms our reputation and causes
the market price of our Ordinary Shares to decline.

Because competition in our
industry is intense, competitors may infringe or otherwise violate our issued patents, patents of our licensors or other intellectual
property. To counter infringement or unauthorized use, we may be required to file infringement claims, which can be expensive and time
consuming, and could distract our technical and management personnel from their normal responsibilities. Any claims we assert against
perceived infringers could provoke these parties to assert counterclaims or file administrative actions against us alleging that we infringe
their patents. In addition, in a patent infringement proceeding, a court may decide that a patent of ours is invalid or unenforceable,
in whole or in part, construe the patent’s claims narrowly or refuse to stop the other party from using the technology at issue
on the grounds that our patents do not cover the technology in question. An adverse result in any